Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 51 to 100 of 9634 in total
Value Type: Measured
Network Comparison Type: Divided

\def\wcA{0.125\textwidth}
\def\wcB{0.125\textwidth}
\def\wcC{0.125\textwidth}
\def\wcD{0.125\textwidth}
\def\wcE{0.125\textwidth}
\def\wcF{0.125\textwidth}
\def\wcG{0.125\textwidth}
\begin{longtable}{|c|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Filtered\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
13\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
fk506-binding protein 6 (ec 5.2.1.8) (peptidyl-prolyl cis-trans isomerase) (ppiase) (rotamase) (36 kda fk506 binding protein) (fkbp- 36) (immunophilin fkbp36). [source:swissprot;acc:o75344]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8.11997\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
115.385\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
14.21\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
jumonji domain containing 1; zinc finger protein; testis-specific protein a. [source:refseq;acc:nm\_018433]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1927.68\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2959.19\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.5351\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
14\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclin h (mo15-associated protein) (p37) (p34). [source:swissprot;acc:p51946]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
130.512\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.50325\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
20.0687\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein beta subunit-like protein 1 (g protein beta-subunit like protein 1) (wd40 repeat containing protein deleted in vcfs) (wdvcf protein) (fksg1 protein) (dgcrk3). [source:swissprot;acc:q9byb4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
59\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5900000\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
ras gtpase-activating protein ngap (ras protein activator like 1). [source:swissprot;acc:q9ujf2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
398.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1281.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.21581\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
trypsin iii precursor (ec 3.4.21.4) (brain trypsinogen) (mesotrypsinogen) (trypsin iv). [source:swissprot;acc:p35030]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
1972.65\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2998.1\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.51983\vspace{3pt}}\\\cline{1-2}\cline{4-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
15\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
lipopolysaccharide-responsive and beige-like anchor protein (cdc4-like protein) (beige-like protein). [source:swissprot;acc:p50851]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
485.286\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2740.13\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5.64642\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial precursor (cybs) (succinate-ubiquinone reductase membrane anchor subunit) (qps2) (cii-4) (succinate dehydrogenase complex subunit d) (succinate-ubiquinone oxidoreductase cytochrome b small subunit). [source:swissprot;acc:o14521]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
10\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
156\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
15.6\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
trypsin i precursor (ec 3.4.21.4) (cationic trypsinogen). [source:swissprot;acc:p07477]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
1983.91\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3007.85\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.51612\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
xpa binding protein 1; mbd2 interactor protein; putative atp(gtp)-binding protein. [source:refseq;acc:nm\_007266]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
2671\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
871\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.06659\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
16\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
28s ribosomal protein s17, mitochondrial precursor (mrp-s17) (hspc011). [source:swissprot;acc:q9y2r5]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
21185\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.34491\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase, lysine deficient 3. [source:refseq;acc:nm\_020922]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
125\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
704.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5.636\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein transport protein sec24c (sec24-related protein c). [source:swissprot;acc:p53992]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
15\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
15\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein x 0004. [source:refseq;acc:nm\_016301]\vspace{3pt}}&&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
2671\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
871\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.06659\vspace{3pt}}\\\cline{1-2}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
17\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dgcr14 protein (digeorge syndrome critical region 14) (es2 protein). [source:swissprot;acc:q96df8]\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
460\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1365\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2.96739\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial solute carrier protein. [source:refseq;acc:nm\_145305]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
21185\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.34491\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
mln 64 protein (star-related lipid transfer protein 3) (stard3) (start domain-containing protein 3) (cab1 protein). [source:swissprot;acc:q14849]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
859\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
58\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
14.8103\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
ptd016 protein. [source:refseq;acc:nm\_016125]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
30\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
158\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5.26667\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
18\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l37a. [source:swissprot;acc:p12751]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
305.45\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
26.1599\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11.6763\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
camp-regulated phosphoprotein 19 (arpp-19) [contains: camp-regulated phosphoprotein 16 (arpp-16)]. [source:swissprot;acc:p56211]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
99\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
19\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5.21053\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
cyclic-amp-dependent transcription factor atf-3 (activating transcription factor 3). [source:swissprot;acc:p18847]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
5492.04\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7251\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.32027\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 14a; 17-kda pkc-potentiated inhibitory protein of pp1. [source:refseq;acc:nm\_033256]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
677.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1865.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2.75351\vspace{3pt}}\\\cline{1-2}\cline{4-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
19\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
25-hydroxyvitamin d-1 alpha hydroxylase, mitochondrial precursor (ec 1.14.-.-) (25-ohd-1 alpha-hydroxylase) (25-hydroxyvitamin d3 1- alpha-hydroxylase) (vd3 1a hydroxylase) (p450c1 alpha) (p450vd1- alpha). [source:swissprot;acc:o15528]\vspace{3pt}}}&&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
305.45\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
26.1599\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11.6763\vspace{3pt}}\\\cline{3-7}
&&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3032.56\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3915.4\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.29112\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
fatty acid desaturase 1; linoleoyl-coa desaturase (delta-6-desaturase)-like 1; delta-5 desaturase; delta-5 fatty acid desaturase. [source:refseq;acc:nm\_013402]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
153\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
662\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
4.3268\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
microfibril-associated glycoprotein 4 precursor. [source:swissprot;acc:p55083]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
677.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1865.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2.75351\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
20\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-carotene dioxygenase 2; putative b,b-carotene-9',10'-dioxygenase. [source:refseq;acc:nm\_031938]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
570\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
139\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
4.10072\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
ero1-like. [source:refseq;acc:nm\_014584]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
82\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
8200000\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory subunit 14d; pkc-dependent pp1 inhibitory protein. [source:refseq;acc:nm\_017726]\vspace{3pt}}&&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
677.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1865.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2.75351\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
retinoblastoma-associated factor 600. [source:refseq;acc:nm\_020765]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
7256.71\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9368.87\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.29106\vspace{3pt}}\\\cline{1-2}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
21\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome p450 27, mitochondrial precursor (ec 1.14.-.-) (cytochrome p-450c27/25) (sterol 26-hydroxylase) (sterol 27-hydroxylase) (vitamin d(3) 25-hydroxylase) (5-beta-cholestane-3-alpha,7-alpha,12-alpha-triol 27-hydroxylase). [source:swissprot;acc:q02318]\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
3035.43\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3917.88\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.29072\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
ficolin 2 precursor (collagen/fibrinogen domain-containing protein 2) (ficolin-b) (ficolin b) (serum lectin p35) (ebp-37) (hucolin) (l- ficolin). [source:swissprot;acc:q15485]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
677.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1865.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2.75351\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
potassium voltage-gated channel, shal-related subfamily, member 2; voltage-sensitive potassium channel; voltage-gated potassium channel kv4.2. [source:refseq;acc:nm\_012281]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
111.278\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
434.911\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.90833\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
syntaxin 10 (syn10). [source:swissprot;acc:o60499]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
118.878\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
17.6611\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
6.73106\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
22\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
carbohydrate (n-acetylglucosamine 6-o) sulfotransferase 6; macular dystrophy, corneal, 1; carbohydate sulfotransferase 6; corneal n-acetylglucosamine 6-sulfotransferase. [source:refseq;acc:nm\_021615]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
37\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3700000\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome p450 24a1, mitochondrial precursor (ec 1.14.-.-) (p450- cc24) (vitamin d(3) 24-hydroxylase) (1,25-dihydroxyvitamin d(3) 24- hydroxylase) (24-ohase). [source:swissprot;acc:q07973]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
3126.88\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3997.02\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.27828\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 14c; serologically defined breast cancer antigen ny-br-81; pkc-potentiated pp1 inhibitory protein. [source:refseq;acc:nm\_030949]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
677.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1865.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2.75351\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
similar to lysozyme c-1 (1,4-beta-n-acylmuramidase c, ec 3.2.1.17). [source:refseq;acc:nm\_032517]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
60\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\parbox{\wcG}{\vspace{3pt}\noindent
6000000\vspace{3pt}}\\\cline{1-3}\cline{5-5}\cline{7-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
23\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
carbohydrate (n-acetylglucosamine-6-o) sulfotransferase 2; carbohydrate (chondroitin 6/keratan) sulfotransferase 2. [source:refseq;acc:nm\_004267]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
37\vspace{3pt}}&&\parbox{\wcG}{\vspace{3pt}\noindent
3700000\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
carboxypeptidase d precursor (ec 3.4.17.-) (gp180). [source:swissprot;acc:o75976]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
40899\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
32028.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.27696\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
gbp protein isoform a. [source:refseq;acc:nm\_017870]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
699.76\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1894.39\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2.7072\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein beta subunit-like protein 1 (g protein beta-subunit like protein 1) (wd40 repeat containing protein deleted in vcfs) (wdvcf protein) (fksg1 protein) (dgcrk3). [source:swissprot;acc:q9byb4]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
59\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5900000\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
24\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
atlastin; guanylate-binding protein 3. [source:refseq;acc:nm\_015915]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5720.25\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
4577.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.24965\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
cathepsin z precursor (ec 3.4.22.-) (cathepsin x) (cathepsin p). [source:swissprot;acc:q9ubr2]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
154\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
493\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.2013\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase, interferon-inducible double stranded rna dependent activator; protein activator of the interferon-induced protein kinase. [source:refseq;acc:nm\_003690]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
950.561\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2108.52\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2.21818\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
ptd016 protein. [source:refseq;acc:nm\_016125]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
30\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
158\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5.26667\vspace{3pt}}\\\cline{1-2}\cline{4-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
25\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-7 subunit. [source:swissprot;acc:o60262]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
1833.01\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
892.67\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2.0534\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
histidine triad nucleotide-binding protein 1 (adenosine 5'- monophosphoramidase) (protein kinase c inhibitor 1) (protein kinase c- interacting protein 1) (pkci-1). [source:swissprot;acc:p49773]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
5847.46\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
4691.96\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.24627\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
lim domain binding 1; carboxy terminal lim domain protein 2; lim domain-binding factor-1. [source:refseq;acc:nm\_003893]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
12.6208\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
39.8063\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.15402\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
potential phospholipid-transporting atpase iia (ec 3.6.1.-). [source:swissprot;acc:o75110]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
148\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
773\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5.22297\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/